Pfizer’s chief executive said that within 12 months of full inoculation, people may need a third dose of the Covid-19 vaccine and may receive an annual booster jab.
“Somewhere in the six to 12 months a third dose will be needed and from there there will be an annual resuscitation,” Albert Borla said in an interview with CVS Health aired Thursday. ”
America is focused on vaccinating millions of people every day, recovering safely from the epidemic, and the amount of annual vaccines, such as the flu vaccine, needed to control the virus in the long run.
Borla’s remarks came after U.S. health officials testified to Congress on how to control the spread of the virus once the epidemic subsided.
David Kessler, chief science officer at the White House Coronavirus Task Force, told a congressional committee: “I think we should expect to be encouraged… And the current thinking is that those who are weak must go first.”
The latest coron virus news
Follow FT’s live coverage and analysis of global epidemics and fast-growing economic crises Here.
“But I think you have a lot of vaccines, we understand that at a certain point in time we need to increase to nine months, 12 months, and we are preparing to come.”
Earlier this month, data from Pfizer and Bioentech showed that their mRNA vaccine was 91 percent effective against the virus six months before the second dose.
“Security decreases from time to time but in six months it is extremely, very final,” Borla said.
In February, the two companies began trailing the third shot of their vaccine on fully vaccinated individuals six to 12 months after their second job, to understand the effects of boosters against immunity and new strains of the virus.
The Bionatech / Pfizer Job Most used Vaccination In the United States, about 103 million doses have been delivered so far, according to data from the Centers for Disease Control and Prevention. Fully vaccinated individuals dose 38.3 million of them.
Earlier this week, Bauer said on Twitter that Pfizer could meet its target of supplying 300 million doses to the U.S. government two weeks before the schedule to increase production.
His CVS interview was filmed some time ago, Pfizer said, before Johnson and Johnson were vaccinated. Paused Fear of blood clots across America
The rollout of the lowest-managed single-shot job in the United States has stalled for at least a week, leading to one death while investigating six cases of rare blood clots by U.S. Prevention Committee advisers.